Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 26,100
-250 (-0.95%)
Oct 2, 2026, 3:30 PM KST
| Market Cap | 153.47B -13.9% |
| Revenue (ttm) | 216.55B +4.3% |
| Net Income | 27.53B -12.1% |
| EPS | 4,681.69 -12.1% |
| Shares Out | 5.88M |
| PE Ratio | 5.57 |
| Forward PE | 5.48 |
| Dividend | 900.00 (3.45%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 10,981 |
| Open | 26,350 |
| Previous Close | 26,350 |
| Day's Range | 25,900 - 26,350 |
| 52-Week Range | 24,000 - 31,650 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |